問卷

TPIDB > Search Result

Search Result

篩選

List

81Cases

2021-12-31 - 2022-12-31

Others

Completed
Real world evidence of Peg-Intron® + Ribavirin to support the non-inferiority of P1101 + Ribavirin in patients with chronic HCV genotype 2 infection/
  • Condition/Disease

    Hepatitis C

  • Test Drug

    Not applicable

Participate Sites
3Sites

Recruiting3Sites

2005-12-01 - 2006-12-01

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Terminated7Sites

2007-06-01 - 2013-12-31

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites

2006-01-31 - 2010-01-31

Phase III

Not yet recruiting
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites

2023-12-26 - 2026-05-14

Phase III

Active
xxxxxx
  • Condition/Disease

    xxxxxx

  • Test Drug

    xxxxxx

Participate Sites
6Sites

Not yet recruiting5Sites

Recruiting1Sites

2023-10-15 - 2025-06-18

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Not yet recruiting1Sites

Recruiting2Sites

2019-10-31 - 2023-10-05

Phase II

Completed
A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
  • Condition/Disease

    Systemic Lupus Erythematosus(SLE)

  • Test Drug

    PF-06700841

Participate Sites
8Sites

Recruiting8Sites

2023-07-14 - 2028-12-31

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2021-10-01 - 2028-07-07

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2021-06-01 - 2026-06-30

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Not yet recruiting3Sites

Recruiting7Sites